Literature DB >> 33587434

Evaluation Within 30 Days of Referral for Liver Transplantation is Associated with Reduced Mortality: A Multicenter Analysis of Patients Referred Within the VA Health System.

Binu V John1, Kaley Schwartz1, Andrew R Scheinberg2, Bassam Dahman3, Seth Spector4,5, Yangyang Deng3, David Goldberg6, Paul Martin6, Tamar H Taddei7,8, David E Kaplan9,10.   

Abstract

BACKGROUND: Successful liver transplantation offers the possibility of improved survival among patients with decompensated cirrhosis. However, there is wide variability in access to care and promptness of the transplant evaluation process in the United States.
METHODS: We performed a multicenter retrospective study of 1118 patients who underwent evaluation for liver transplantation at the 6 Veterans Affairs' transplant centers from 2013 to 2018. Of these, 832 patients were evaluated within 30 d and 286 > 30 d after referral. We studied the differential effects of the time from referral to evaluation on pretransplant and posttransplant mortality and transplant list dropout and explored predictors of early transplant evaluation.
RESULTS: Patients in the early evaluation group had a shorter adjusted time from referral to listing by 29.5 d (95% confidence interval [CI] -50.4, -8.5, P < 0.006), and referral to transplantation by 115.1 d (95% CI -179.5, -50.7, P < 0.0001). On a multivariable Cox hazard model, evaluation within 30 d of referral was associated with a significantly lower pretransplant mortality (adjusted hazard ratio [aHR] 0.70, 95% CI 0.54-0.91, P < 0.01), but not associated with transplant list dropout (aHR 0.95, 95% CI 0.65-1.39, P = 0.79) or posttransplant death (aHR 1.88, 95% CI 0.72-4.9, P = 0.20). An early evaluation within 30 d was positively associated with a higher MELD at referral (aHR 1.03, 95% CI 1.01-1.06, P = 0.006) and negatively associated with distance from the transplant center (aHR 0.99, 95% CI 0.99-0.99, P = 0.045).
CONCLUSIONS: Evaluation of patients referred for liver transplantation within 30 d is associated with a reduction in pretransplant mortality.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 33587434      PMCID: PMC8239056          DOI: 10.1097/TP.0000000000003615

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   5.385


  15 in total

1.  Liver transplants among US veterans.

Authors:  William P Gunnar
Journal:  JAMA       Date:  2014 Jul 23-30       Impact factor: 56.272

2.  Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.

Authors:  Paul Martin; Andrea DiMartini; Sandy Feng; Robert Brown; Michael Fallon
Journal:  Hepatology       Date:  2014-03       Impact factor: 17.425

3.  Development and validation of a comorbidity scoring system for patients with cirrhosis.

Authors:  Peter Jepsen; Hendrik Vilstrup; Timothy L Lash
Journal:  Gastroenterology       Date:  2013-09-18       Impact factor: 22.682

4.  Telehealth-Based Evaluation Identifies Patients Who Are Not Candidates for Liver Transplantation.

Authors:  Venkata Rajesh Konjeti; Douglas Heuman; Jasmohan S Bajaj; HoChong Gilles; Michael Fuchs; Phillip Tarkington; Binu V John
Journal:  Clin Gastroenterol Hepatol       Date:  2018-04-30       Impact factor: 11.382

5.  Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.

Authors:  Lauren A Beste; Steven L Leipertz; Pamela K Green; Jason A Dominitz; David Ross; George N Ioannou
Journal:  Gastroenterology       Date:  2015-08-05       Impact factor: 22.682

6.  Prevalence of clinically recognized alcohol and other substance use disorders among VA outpatients with unhealthy alcohol use identified by routine alcohol screening.

Authors:  Emily C Williams; Anna D Rubinsky; Gwen T Lapham; Laura J Chavez; Stacey E Rittmueller; Eric J Hawkins; Joel R Grossbard; Daniel R Kivlahan; Katharine A Bradley
Journal:  Drug Alcohol Depend       Date:  2013-11-27       Impact factor: 4.492

7.  AUDIT-C as a brief screen for alcohol misuse in primary care.

Authors:  Katharine A Bradley; Anna F DeBenedetti; Robert J Volk; Emily C Williams; Danielle Frank; Daniel R Kivlahan
Journal:  Alcohol Clin Exp Res       Date:  2007-04-19       Impact factor: 3.455

8.  Use of Telehealth Expedites Evaluation and Listing of Patients Referred for Liver Transplantation.

Authors:  Binu V John; Eleanor Love; Bassam Dahman; Nargiza Kurbanova; Venkata Rajesh Konjeti; Latha Thankam Sundaram; Yangyang Deng; Sean Aubuchon; Douglas Heuman; Jasmohan S Bajaj; Hochong Gilles; Michael Chang; Rehan Qayyum; Mohammad S Siddiqui
Journal:  Clin Gastroenterol Hepatol       Date:  2019-12-27       Impact factor: 11.382

9.  Effects of Metformin Exposure on Survival in a Large National Cohort of Patients With Diabetes and Cirrhosis.

Authors:  David E Kaplan; Marina Serper; Binu V John; Kristen M Tessiatore; Renata Lerer; Rajni Mehta; Rena Fox; Ayse Aytaman; Michelle Baytarian; Kristel Hunt; Jeffrey Albrecht; Tamar H Taddei
Journal:  Clin Gastroenterol Hepatol       Date:  2020-08-13       Impact factor: 11.382

10.  Effects of Hypercholesterolemia and Statin Exposure on Survival in a Large National Cohort of Patients With Cirrhosis.

Authors:  David E Kaplan; Marina A Serper; Rajni Mehta; Rena Fox; Binu John; Ayse Aytaman; Michelle Baytarian; Kristel Hunt; Jeffrey Albrecht; Basile Njei; Tamar H Taddei
Journal:  Gastroenterology       Date:  2019-01-18       Impact factor: 22.682

View more
  1 in total

Review 1.  The Future of Quality Improvement for Cirrhosis.

Authors:  Elliot B Tapper; Neehar D Parikh
Journal:  Liver Transpl       Date:  2021-07-31       Impact factor: 6.112

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.